Zyentia (AggreSolve Technology Platform) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Zyentia (AggreSolve Technology Platform) General Information
Description
A silico protein analysis platform. The silico protein analysis platform is used to screen proteins to predict aggregation problems, to predict sequence changes likely to reduce aggregation and to design aggregation inhibitors and stabilizers.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- Cambridge
- England, United Kingdom
Zyentia (AggreSolve Technology Platform) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zyentia (AggreSolve Technology Platform) Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jesús Zurdo | Founder |
Zyentia (AggreSolve Technology Platform) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|